Metavia (MTVA) traded down -0.72 % during a 24 hours period ending at 05:00 PM Central Europe on Monday 26th. One Metavia stock can currently be bought for about USD 1.25 on popular exchanges. Current supply of Metavia stocks is 6.6 mn. Metavia has a current market capitalization of USD 9.1 mn and approximately USD 137.4 k worth of Metavia was traded on exchanges in the last 24 hours. Since last month end, Metavia has traded -15.34 % down. Simple moving average of last 200 days is at USD 1.84. The highest price of past 52 weeks was recorded at USD 14.85 on 11/05/2025. 52 weeks low was at USD 0.97 on 05/12/2026.
Here is how related stocks have performed in the past 24 hours:
Adial (ADIL) traded down -7.11 % and now trades at USD 3.74. Adial has a market capitalisation of USD 10.3 mn.
In8bio (INAB) traded up 6.49 % and now trades at USD 0.98. Current market capitalisation for In8bio is USD 10.4 mn.
Intensity Therapeutics (INTS) traded up 1.88 % and now trades at USD 3.16. Intensity Therapeutics has a market capitalisation of USD 10.6 mn.
Passage Bio (PASG) traded down -3.99 % and now trades at USD 3.36. Current market capitalisation for Passage Bio is USD 10.8 mn.
About Metavia
NeuroBo Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Northville, United States, which specializes in developing and commercializing therapies for the treatment of dyslipidemia.